SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Life Sciences Summit
Event | 11. 02. 2022
Peter Young will be participating on a panel titled "Investor and Partner Insights" on November 2nd at the virtual Life Sciences Summit.
